NextCell Pharma AB
Sofia Sisay is an experienced Clinical Trial Manager currently employed at NextCell Pharma AB since April 2022, with a strong background in clinical research and project management. Previous roles include Deputy Head of Unit and Group Manager at Karolinska Trial Alliance, where responsibilities encompassed managing clinical cell therapy projects in oncology, overseeing clinical trial coordination and monitoring, as well as handling regulatory applications and protocol writing. Prior to that, Sofia worked as a Clinical Research Associate at PPD, focusing on project management in oncology and chronic obstructive pulmonary disease, and as a Postdoctoral Research Scientist at Barts and the London School of Medicine and Dentistry, where clinical and scientific project management skills were further developed. Educational qualifications include a Ph.D. in Neuroscience/Neuroimmunology from Queen Mary University of London and advanced degrees in Biomedical Sciences from Karolinska Institutet.
This person is not in any teams
NextCell Pharma AB
NextCell Pharma is an innovative Biotech growing out of the need for Advanced Therapy Medicinal Products for Autoimmune Disease and Transplantation. Cellaviva, the first Swedish family saving stem cell bank, with its expertise in umbilical cord stem cells and Diamyd Medical with its interests and investments within autoimmune diseases made a natural partnership for creating NextCell Pharma. Clinical trials testing NextCell Pharma’s first product, ProTrans,has started in Novermber 2018. #nextcellpharma #cellaviva